Nikulski Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.59M | Buy |
38,111
+629
| +2% | +$135K | 2.07% | 12 |
|
|
2026
Q1 | $8.15M | Sell |
37,482
-1,042
| -3% | -$231K | 2.01% | 12 |
|
|
2025
Q4 | $8.8M | Sell |
38,524
-815
| -2% | -$186K | 2.1% | 9 |
|
|
2025
Q3 | $9.11M | Sell |
39,339
-332
| -0.8% | -$67.6K | 2.29% | 12 |
|
|
2025
Q2 | $7.36M | Buy |
39,671
+775
| +2% | +$144K | 2.02% | 15 |
|
|
2025
Q1 | $8.15M | Sell |
38,896
-81
| -0.2% | -$15.7K | 2.46% | 10 |
|
|
2024
Q4 | $6.93M | Buy |
38,977
+1,171
| +3% | +$215K | 2.04% | 15 |
|
|
2024
Q3 | $7.47M | Buy |
37,806
+264
| +0.7% | +$49.3K | 2.23% | 14 |
|
|
2024
Q2 | $6.44M | Sell |
37,542
-769
| -2% | -$127K | 2.05% | 16 |
|
|
2024
Q1 | $6.98M | Sell |
38,311
-383
| -1% | -$66K | 2.31% | 13 |
|
|
2023
Q4 | $6M | Sell |
38,694
-576
| -1% | -$84K | 2.2% | 14 |
|
|
2023
Q3 | $5.85M | Buy |
39,270
+5,651
| +17% | +$830K | 2.42% | 12 |
|
|
2023
Q2 | $4.53M | Buy |
33,619
+1,079
| +3% | +$158K | 1.87% | 16 |
|
|
2023
Q1 | $5.19M | Sell |
32,540
-318
| -1% | -$48.6K | 2.29% | 13 |
|
|
2022
Q4 | $5.31M | Buy |
32,858
+120
| +0.4% | +$18.4K | 2.53% | 10 |
|
|
2022
Q3 | $4.39M | Buy |
32,738
+100
| +0.3% | +$14.3K | 2.27% | 13 |
|
|
2022
Q2 | $5M | Sell |
32,638
-75
| -0.2% | -$11.5K | 2.48% | 11 |
|
|
2022
Q1 | $5.3M | Buy |
32,713
+691
| +2% | +$100K | 2.24% | 12 |
|
|
2021
Q4 | $4.34M | Buy |
32,022
+1,075
| +3% | +$127K | 1.82% | 16 |
|
|
2021
Q3 | $3.34M | Buy |
30,947
+663
| +2% | +$75.8K | 1.54% | 20 |
|
|
2021
Q2 | $3.54M | Sell |
30,284
-554
| -2% | -$62.4K | 1.65% | 19 |
|
|
2021
Q1 | $3.34M | Sell |
30,838
-378
| -1% | -$40.4K | 1.71% | 17 |
|
|
2020
Q4 | $3.35M | Buy |
31,216
+1,661
| +6% | +$160K | 1.83% | 16 |
|
|
2020
Q3 | $2.59M | Buy |
29,555
+487
| +2% | +$45.8K | 1.64% | 17 |
|
|
2020
Q2 | $2.85M | Buy |
29,068
+582
| +2% | +$51.2K | 2% | 14 |
|
|
2020
Q1 | $2.17M | Sell |
28,486
-1,804
| -6% | -$154K | 1.89% | 16 |
|
|
2019
Q4 | $2.52M | Sell |
30,290
-737
| -2% | -$61.2K | 1.82% | 18 |
|
|
2019
Q3 | $2.29M | Buy |
31,027
+1,118
| +4% | +$76.7K | 1.9% | 18 |
|
|
2019
Q2 | $2.04M | Sell |
29,909
-3,644
| -11% | -$286K | 1.73% | 20 |
|
|
2019
Q1 | $2.7M | Sell |
33,553
-2,040
| -6% | -$167K | 2.63% | 13 |
|
|
2018
Q4 | $3.28M | Sell |
35,593
-796
| -2% | -$70K | 3.44% | 7 |
|
|
2018
Q3 | $2.83M | Buy |
36,389
+5,306
| +17% | +$503K | 2.64% | 14 |
|
|
2018
Q2 | $2.88M | Buy |
31,083
+506
| +2% | +$49.4K | 2.65% | 14 |
|
|
2018
Q1 | $2.89M | Buy |
30,577
+1,854
| +6% | +$204K | 2.87% | 12 |
|
|
2017
Q4 | $2.78M | Buy |
+28,723
| New | +$2.71M | 3% | 11 |
|
Other funds holding ABBV
ECSS
ATO
Nikulski Financial's ABBV Position: Q2 2026 in Review
Nikulski Financial increased its AbbVie (ABBV) stake by 1.7% in Q2 2026, buying an estimated $135K and bringing the position to 38,111 shares worth $9.59M. The position accounts for 2.07% of the portfolio, ranked #12.
Nikulski Financial first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. 1,903 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Nikulski Financial held 38,111 shares of AbbVie worth $9.59M as of Q2 2026.
- Nikulski Financial bought 629 AbbVie shares in Q2 2026, an estimated $135K.
- AbbVie made up 2.07% of Nikulski Financial's portfolio in Q2 2026, its #12 holding.
- Nikulski Financial first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
- 1,903 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Nikulski Financial's 13F filing for Q2 2026, filed 28 Jul 2026.